{
    "clinical_study": {
        "@rank": "75523", 
        "arm_group": [
            {
                "arm_group_label": "Polyethylene glycol small dose", 
                "arm_group_type": "Experimental", 
                "description": "Polyethylene glycol 4000: 0.3 g/kg/day for 6 weeks"
            }, 
            {
                "arm_group_label": "Polyethylene glycol high dose", 
                "arm_group_type": "Active Comparator", 
                "description": "Polyethylene glycol 4000: 0.7g/kg for 6 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Background:\n\n      Aim:\n\n      Clinical evaluation of the effectiveness of two different polyethylene glycol doses for the\n      maintenance treatment of functional constipation in children.\n\n      Study design:\n\n      Randomized, open-label trial.\n\n      Randomized, double-blind, placebo controlled trial."
        }, 
        "brief_title": "Polyethylene Glycol for Childhood Constipation", 
        "condition": "Constipation", 
        "condition_browse": {
            "mesh_term": "Constipation"
        }, 
        "detailed_description": {
            "textblock": "Children will be randomly assigned into 2 groups receiving polyethylene glycol 4000 (Forlax)\n      with an initial dose of either 0.3g/kg, or 0.7 g / kg.\n\n      In case of ineffectiveness  the dose of medication will be increased every two weeks with\n      0.2 g/kg. The indication for the increase in dose will be less than 3 bowel movements per\n      week. For children with diarrhea defined as more than 3 loose stools for minimum 2 days\n      or/and severe abdominal pain the macrogol dose of will be reduced every two weeks by 0.2\n      g/kg. The intervention will last 6 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 1 - 18 age\n\n          -  functional constipation according to the Rome III Criteria\n\n          -  consent of parents or guardians of the child to participate and study\n\n        Exclusion Criteria:\n\n          -  organic cause constipation (including surgeries within the lower GI tract)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875744", 
            "org_study_id": "2/2013", 
            "secondary_id": "2/2013"
        }, 
        "intervention": {
            "arm_group_label": [
                "Polyethylene glycol small dose", 
                "Polyethylene glycol high dose"
            ], 
            "intervention_name": "Polyethylene glycol 4000", 
            "intervention_type": "Drug", 
            "other_name": "Forlax"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "constipation", 
            "children", 
            "polyethylene glycol"
        ], 
        "lastchanged_date": "November 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Warsaw", 
                    "country": "Poland", 
                    "zip": "01-184"
                }, 
                "name": "Dpt of Pediatrics The Medical University of Warsaw"
            }, 
            "investigator": {
                "last_name": "Piotr Dziechciarz, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "piotrdz@hotmail.com", 
            "last_name": "Piotr Dziechciarz, MD", 
            "phone": "4822-4523292"
        }, 
        "overall_contact_backup": {
            "email": "andrea.hania@gmail.com", 
            "last_name": "Andrea Horvath, MD", 
            "phone": "4822-4523292"
        }, 
        "overall_official": {
            "affiliation": "Medical University of Warsaw", 
            "last_name": "Andrea Horvath, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "therapeutic success (passing \u2265 3 stools per week, with no loosening of stool).", 
            "safety_issue": "No", 
            "time_frame": "the number and consistency of the stool will be recorded at 6th week of intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875744"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Warsaw", 
            "investigator_full_name": "Andrea Horvath-Stolarczyk", 
            "investigator_title": "MD PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "the number of stools delivered at 6th week of intervention", 
                "safety_issue": "No", 
                "time_frame": "the number of the stools will be recorded at the 6th week of intervention"
            }, 
            {
                "measure": "the number of incontinence episodes", 
                "safety_issue": "No", 
                "time_frame": "the number of the incontinence episodes will be recorded at the 6th week of intervention"
            }, 
            {
                "measure": "the number of painful defecation", 
                "safety_issue": "No", 
                "time_frame": "the number of painful defecation will be recorded at the 6th week of intervention"
            }, 
            {
                "measure": "the number of episodes of abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "the number of the episodes of abdominal pain will be recorded at the 6th week of intervention"
            }, 
            {
                "measure": "the number of patients needed laxatives during treatment", 
                "safety_issue": "No", 
                "time_frame": "the number patiens needed laxatives will be recorded for six weeks of intervention"
            }, 
            {
                "description": "the number and character of the sides effects will be recorded by the patient at the diary during the 6 weeks of the intervention", 
                "measure": "side effects", 
                "safety_issue": "Yes", 
                "time_frame": "the number and the character of the side effects will be recorded for six weeks of intervention"
            }
        ], 
        "source": "Medical University of Warsaw", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Warsaw", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}